Dataset | double_gel_and_single_gel_rma_expression_values_collapsed_to_symbols.class.cls #double_gel_8d_versus_double_gel_24h.class.cls #double_gel_8d_versus_double_gel_24h_repos |
Phenotype | class.cls#double_gel_8d_versus_double_gel_24h_repos |
Upregulated in class | double_gel_24h |
GeneSet | LIAN_MYELOID_DIFF_TF |
Enrichment Score (ES) | -0.53068835 |
Normalized Enrichment Score (NES) | -1.5190138 |
Nominal p-value | 0.034412954 |
FDR q-value | 0.22420883 |
FWER p-Value | 1.0 |
PROBE | GENE SYMBOL | GENE_TITLE | RANK IN GENE LIST | RANK METRIC SCORE | RUNNING ES | CORE ENRICHMENT | |
---|---|---|---|---|---|---|---|
1 | AES | AES Entrez,  Source | amino-terminal enhancer of split | 1989 | 0.108 | -0.0990 | No |
2 | MAX | MAX Entrez,  Source | MYC associated factor X | 2495 | 0.088 | -0.0961 | No |
3 | CEBPD | CEBPD Entrez,  Source | CCAAT/enhancer binding protein (C/EBP), delta | 2628 | 0.083 | -0.0675 | No |
4 | ID1 | ID1 Entrez,  Source | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 3286 | 0.063 | -0.0875 | No |
5 | NFKB1 | NFKB1 Entrez,  Source | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) | 4778 | 0.028 | -0.1863 | No |
6 | MPDU1 | MPDU1 Entrez,  Source | mannose-P-dolichol utilization defect 1 | 5578 | 0.013 | -0.2402 | No |
7 | RELA | RELA Entrez,  Source | v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, p65 (avian) | 5892 | 0.007 | -0.2603 | No |
8 | CEBPB | CEBPB Entrez,  Source | CCAAT/enhancer binding protein (C/EBP), beta | 6062 | 0.004 | -0.2712 | No |
9 | GATA2 | GATA2 Entrez,  Source | GATA binding protein 2 | 6947 | -0.011 | -0.3323 | No |
10 | IRF1 | IRF1 Entrez,  Source | interferon regulatory factor 1 | 7528 | -0.022 | -0.3656 | No |
11 | SREBF1 | SREBF1 Entrez,  Source | sterol regulatory element binding transcription factor 1 | 7713 | -0.026 | -0.3675 | No |
12 | LYL1 | LYL1 Entrez,  Source | lymphoblastic leukemia derived sequence 1 | 7941 | -0.030 | -0.3705 | No |
13 | LITAF | LITAF Entrez,  Source | lipopolysaccharide-induced TNF factor | 8233 | -0.036 | -0.3756 | No |
14 | USF2 | USF2 Entrez,  Source | upstream transcription factor 2, c-fos interacting | 10299 | -0.084 | -0.4914 | Yes |
15 | NFE2 | NFE2 Entrez,  Source | nuclear factor (erythroid-derived 2), 45kDa | 10313 | -0.085 | -0.4529 | Yes |
16 | STAT3 | STAT3 Entrez,  Source | signal transducer and activator of transcription 3 (acute-phase response factor) | 10664 | -0.096 | -0.4347 | Yes |
17 | PAM | PAM Entrez,  Source | peptidylglycine alpha-amidating monooxygenase | 10944 | -0.106 | -0.4062 | Yes |
18 | TRIM28 | TRIM28 Entrez,  Source | tripartite motif-containing 28 | 11023 | -0.109 | -0.3615 | Yes |
19 | ID2 | ID2 Entrez,  Source | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein | 11229 | -0.117 | -0.3225 | Yes |
20 | TP53 | TP53 Entrez,  Source | tumor protein p53 (Li-Fraumeni syndrome) | 11266 | -0.119 | -0.2699 | Yes |
21 | MYC | MYC Entrez,  Source | v-myc myelocytomatosis viral oncogene homolog (avian) | 12249 | -0.175 | -0.2622 | Yes |
22 | HMGA1 | HMGA1 Entrez,  Source | high mobility group AT-hook 1 | 12748 | -0.232 | -0.1916 | Yes |
23 | CEBPA | CEBPA Entrez,  Source | CCAAT/enhancer binding protein (C/EBP), alpha | 12827 | -0.248 | -0.0821 | Yes |
24 | BHLHB2 | BHLHB2 Entrez,  Source | basic helix-loop-helix domain containing, class B, 2 | 12874 | -0.260 | 0.0351 | Yes |